My watch list  

87 Current news of High-Tech Gründerfonds Management


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Spin-off from Charité want to advance AI-powered pathology

Aignostics Raises €5 Million Seed Round


Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the round, ...


image description
Atriva announces closing of € 8.6 million oversubscribed convertible loan

Proceeds to be used to start Phase II study with ATR-002 in moderate to severe COVID-19 and clinical development in influenza and other respiratory viral infections


Atriva Therapeutics GmbH, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, announced the closing of a € 8.6 million ($ 10.2 million) convertible loan led by Meneldor B.V. and High-Tech Gründerfonds (HTGF), and joined by existing shareholders and new ...


image description
Tubulis Raises €10.7 M Series A

Further Development of a New Generation of Antibody-Drug Conjugates


Tubulis announced the close of a €10.7 million Series A financing round to accelerate the development of a new class of highly stable and efficient antibody-drug conjugates (ADCs) and to support the further growth of the company. The financing round was co-led by BioMedPartners and High-Tech ...


image description
3D printer for medicine

Kumovis closes Series A funding led by Renolit and Solvay


Kumovis, the developer of the world’s first 3D printer with clean room integration, announced that it has raised a €3.6 million Series A funding round. In Renolit SE and Solvay Ventures, the Munich-based start-up has found two additional partners on its way to establish industrial additive ...


image description
€6 M to develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing

Paris-based biotechnology startup raises Series A financing


Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of ...


image description
Tyrolean virtual reality start-up receives seven-figure growth financing

Products tailored towards the Life Science industry


As a pioneer in education technology, Innerspace develops novel, psychologically based training solutions for highly critical applications in the life science industry. Cleanroom operators are comprehensively prepared for the key moments of their work using the DeepTraining approach, implemented ...


image description
€11 Mio. for the treatment of acute and chronic liver diseases

HepaRegeniX secures Series B Financing


Preclinical data demonstrate efficacy of MKK4 inhibitors in liver regeneration and experimental acute and chronic liver disease models. HepaRegeniX GmbH, a preclinical stage company developing a novel therapy for the treatment of acute and chronic liver diseases announced the closing of its ...


Biograil secures seed funding for oral delivery device with potential to transform market for injectables


Biograil ApS, an innovative biotechnology company developing a unique oral device for delivery of biologics that would otherwise be injected, announced the closing of a seed funding of 3 Million Euro (with potential to expand to 5 Million Euro). The investor Syndicate was led by the experienced ...


Cunesoft joins forces with Phlexglobal


The Munich-based Cunesoft GmbH, an provider of cloud-based intelligent regulatory data management software and services for the life sciences industry, announced that it has been acquired by Phlexglobal from current investors including Bayern Kapital, High-Tech Gründerfonds and ...


image description
Removal Of Tumor Cells From Surgical Blood

Over 5 Million Euros For Lindis Blood Care


As is standard during tumor surgeries, when large volumes of blood are lost, donor blood is given to the patient. Worldwide, this is the case for more than half a million tumor surgeries annually. This procedure can result in many serious side effects and increased tumor recurrence rates. ...


Page 1 From 9
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE